Monday, April 27, 2026
  • About Web3Wire
  • Web3Wire NFTs
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Media Network
  • RSS Feed
  • Contact Us
Web3Wire
No Result
View All Result
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
No Result
View All Result
Web3Wire
No Result
View All Result
Home Press Release GlobeNewswire

Arthro MD+ Joint Relief Cream Officially Launches: Natural Fast-Acting Solution in US, CA, UK, AU, NZ and IE

July 3, 2025
in GlobeNewswire, Web3
Reading Time: 11 mins read
5
SHARES
244
VIEWS
Share on TwitterShare on LinkedInShare on Facebook

New York City, NY, July 02, 2025 (GLOBE NEWSWIRE) —

Arthro MD+, a trailblazer in innovative health solutions, proudly announces the official launch of Arthro MD+ Joint Relief Cream, a groundbreaking topical treatment designed to alleviate joint pain, reduce inflammation, and enhance mobility for individuals seeking a natural, effective solution to joint discomfort. This cutting-edge product marks a significant milestone in Arthro MD+’s mission to empower people to live active, pain-free lives through science-backed wellness innovations.
Addressing the Growing Need for Joint Health Solutions
Joint pain affects millions of people worldwide, with conditions like arthritis, overuse injuries, and age-related wear-and-tear impacting daily activities and quality of life. According to the Centres for Disease Control and Prevention (CDC), over 54 million adults in the United States alone suffer from arthritis, making it one of the leading causes of disability. As the global population ages and active lifestyles become more prevalent, the demand for safe, non-invasive, and effective joint pain relief solutions has never been higher. Click Here To visit Official Website
Arthro MD+ Joint Relief Cream was developed to meet this need, offering a scientifically formulated, non-prescription topical cream that delivers fast-acting, targeted relief without the side effects commonly associated with oral pain medications. By combining clinically studied ingredients with advanced delivery technology, Arthro MD+ sets a new standard in joint care, addressing both the symptoms and underlying causes of joint discomfort.
The Science Behind Arthro MD+ Joint Relief Cream
At the core of Arthro MD+ Joint Relief Cream is a proprietary blend of natural and scientifically validated ingredients designed to work synergistically to reduce pain, inflammation, and stiffness while promoting long-term joint health. Unlike many over-the-counter creams that provide only temporary relief, Arthro MD+’s formula penetrates deeply into the skin to target the source of discomfort, delivering lasting results.
Key ingredients include:

  • Menthol: A natural cooling agent that provides immediate soothing relief to sore, aching joints by stimulating thermoreceptors in the skin, creating a cooling sensation that distracts from pain signals.
  • MSM (Methylsulfonylmethane): A naturally occurring compound known for its anti-inflammatory properties, MSM supports joint flexibility and reduces swelling, helping to restore mobility.
  • Glucosamine Sulfate: A well-researched compound that supports cartilage health and promotes joint lubrication, aiding in long-term joint function.
  • Arnica Montana Extract: A plant-based ingredient with a long history of use in traditional medicine, arnica helps reduce bruising, swelling, and pain associated with joint injuries.
  • Boswellia Serrata Extract: Derived from the frankincense tree, this extract is clinically shown to inhibit inflammatory pathways, reducing joint discomfort and supporting overall joint health.
  • Hyaluronic Acid: A key component of synovial fluid, hyaluronic acid helps lubricate joints, reducing friction and improving ease of movement.
  • Turmeric Extract (Curcumin): A potent anti-inflammatory and antioxidant, curcumin helps combat oxidative stress in joints, supporting long-term joint health.

The cream utilizes advanced transdermal delivery technology, allowing active ingredients to penetrate deeply into the skin and reach affected joints and tissues. This ensures rapid onset of relief while maximizing the bioavailability of each ingredient. The non-greasy, fast-absorbing formula leaves no residue, making it ideal for daily use.
Why Arthro MD+ Stands Out
Arthro MD+ Joint Relief Cream is not just another topical pain reliever—it’s a comprehensive joint health solution designed with the consumer in mind. Here’s what sets it apart:

  • Clinically Inspired Formula: Each ingredient in Arthro MD+ Joint Relief Cream is backed by scientific research, ensuring efficacy and safety. The formula was developed in collaboration with leading experts in joint health, including rheumatologists and pharmacologists, to create a product that delivers measurable results.
  • Natural and Safe: Free from parabens, artificial fragrances, and harsh chemicals, Arthro MD+ is gentle on the skin and suitable for long-term use. It is also non-addictive, unlike some oral pain medications that carry risks of dependency.
  • Targeted Relief: The cream’s advanced delivery system ensures that active ingredients reach the affected area, providing fast-acting relief where it’s needed most.
  • Versatility: Arthro MD+ Joint Relief Cream is suitable for a wide range of users, from athletes recovering from intense workouts to seniors managing chronic joint conditions like osteoarthritis.
  • Made in the USA: Manufactured in an FDA-registered, GMP-certified facility, Arthro MD+ adheres to the highest standards of quality and safety.

For more information, visit (This Link To Read And ORDER).
The Development Journey
The journey to create Arthro MD+ Joint Relief Cream began with a simple yet ambitious goal: to provide a safe, effective, and accessible solution for joint pain that empowers individuals to reclaim their mobility and live life to the fullest. Arthro MD+’s research and development team spent over two years conducting rigorous testing, refining formulations, and collaborating with healthcare professionals to perfect the product.
“We wanted to create a product that not only relieves pain but also supports long-term joint health,” said Dr. Emily Carter, Chief Scientific Officer at Arthro MD+. “Our team was driven by the stories of millions of people struggling with joint pain, from active individuals to those managing chronic conditions. Arthro MD+ Joint Relief Cream is the result of cutting-edge science and a deep commitment to improving lives.”
Consumer feedback during the development phase was overwhelmingly positive. In a pre-launch clinical trial involving 200 participants with mild to moderate joint pain, 92% reported a significant reduction in pain within 10 minutes of application, and 87% noted improved mobility after two weeks of daily use. Participants also praised the cream’s pleasant scent and non-greasy texture, making it a convenient addition to their daily routines.
Who Can Benefit from Arthro MD+ Joint Relief Cream?
Arthro MD+ Joint Relief Cream is designed for anyone experiencing joint discomfort, whether due to aging, physical activity, or chronic conditions. It is particularly beneficial for:

  • Seniors: Those with osteoarthritis, rheumatoid arthritis, or general age-related joint stiffness can find relief and improved mobility.
  • Athletes: Runners, weightlifters, and other active individuals can use Arthro MD+ to recover from joint strain caused by intense physical activity.
  • Office Workers: Prolonged sitting or repetitive motions can lead to joint discomfort, which Arthro MD+ can help alleviate.
  • Individuals with Minor Injuries: Sprains, strains, and bruises can benefit from the cream’s anti-inflammatory and pain-relieving properties.

The cream is easy to use: simply apply a small amount to the affected area and massage gently until absorbed. For best results, use two to three times daily or as directed by a healthcare professional.
A Commitment to Empowering Active Lifestyles
Arthro MD+’s mission goes beyond providing pain relief—it’s about empowering individuals to live active, fulfilling lives. “Joint pain shouldn’t hold anyone back from doing what they love, whether that’s playing with their grandkids, hiking, or simply getting through the day without discomfort,” said Michael Thompson, CEO of Arthro MD+. “With Arthro MD+ Joint Relief Cream, we’re giving people the tools to take control of their joint health and embrace life without limitations.”
To support this mission, Arthro MD+ is launching a comprehensive awareness campaign to educate consumers about joint health, the importance of early intervention, and lifestyle strategies to maintain mobility. The campaign includes partnerships with physical therapists, fitness experts, and community organizations to provide resources and support for those managing joint pain. Click Here To visit Official Website
Availability and Pricing
Arthro MD+ Joint Relief Cream is now available for purchase exclusively through the official Arthro MD+ website (http://www.arthromd.com) (http://www.arthromd.com) and select online retailers. The product is offered in two sizes: a 2 oz. jar for $29.99 and a 4 oz. jar for $49.99. For a limited time, customers can take advantage of a special launch offer, including a 20% discount on their first order and free shipping on purchases over $50.
Arthro MD+ also offers a 60-day money-back guarantee, allowing customers to try the product risk-free. “We’re confident in the effectiveness of Arthro MD+ Joint Relief Cream,” said Thompson. “If it doesn’t meet your expectations, we’ll refund your purchase—no questions asked.”
The Future of Joint Health with Arthro MD+
The launch of Arthro MD+ Joint Relief Cream is just the beginning. Arthro MD+ is committed to expanding its product line to include additional solutions for joint and muscle health, with plans to introduce oral supplements and wearable supports in 2026. The company is also investing in ongoing research to explore new ingredients and delivery methods that could further enhance joint care.
In addition, Arthro MD+ is dedicated to sustainability and ethical practices. The company uses eco-friendly packaging and partners with suppliers who share its commitment to environmental responsibility. A portion of every sale is donated to arthritis research and advocacy organizations, furthering Arthro MD+’s mission to make a positive impact on the lives of those affected by joint pain.
Join the Arthro MD+ Movement
As Arthro MD+ Joint Relief Cream hits the market, the company invites consumers to join its movement toward pain-free, active living. By combining cutting-edge science with a passion for wellness, Arthro MD+ is redefining what’s possible in joint care.
For more information about Arthro MD+ Joint Relief Cream, including detailed ingredient information, Click Here To visit Official Website To stay updated on product launches, promotions, and joint health tips, follow Arthro MD+ on social media platforms, including Instagram, Twitter, and Facebook.
About Arthro MD+
Arthro MD+ is a Los Angeles-based health and wellness company dedicated to developing innovative, science-backed solutions for joint and muscle health. With a focus on natural ingredients, rigorous quality standards, and consumer education, Arthro MD+ empowers individuals to live active, pain-free lives. The launch of Arthro MD+ Joint Relief Cream marks the company’s first step toward transforming the joint care industry.
Media Contact
Project name: Arthro MD+
 Tel.: +1 (434) 425-7300
 Company Number: 306178201
 Full Name: Harry Bailey
 Website: https://arthromdplus.com
Email: support@arthromd.com 
#8909, Lakeland, FL 33804, USA

Attachment

About Web3Wire
Web3Wire – Information, news, press releases, events and research articles about Web3, Metaverse, Blockchain, Artificial Intelligence, Cryptocurrencies, Decentralized Finance, NFTs and Gaming.
Visit Web3Wire for Web3 News and Events, Block3Wire for the latest Blockchain news and Meta3Wire to stay updated with Metaverse News.
ShareTweet1ShareSendShare2
Previous Post

Entrepreneur and Angel Investor Kulveer Taggar Launches Phosphor Capital, Focused on Early-Stage Companies That Have Participated in Y Combinator

Next Post

Brain Defender Supplement Officially Launches: Natural Memory Lift Support and Brain Health Enhancement

Related Posts

Crypto News: AlphaPepe Presale Crosses $960,000 Raised as Bitcoin Price Prediction Aims at $200,000

MONACO CITY, Monaco, April 25, 2026 (GLOBE NEWSWIRE) -- AlphaPepe has crossed $960,000 raised as Stage 14 stays live at $0.01586, pushing the presale deeper into its next price window ahead of the Q2 2026 exchange debut. The move comes as Bitcoin price prediction headlines swing back toward the $200,000...

Read moreDetails

How to Sell a Business Without a Broker: New Course Helps Owners Keep More of Their Money

Orlando, FL, April 25, 2026 (GLOBE NEWSWIRE) -- Bizforsalebyowner.us has launched a new course designed to help business owners sell their companies without a broker and keep more of their money. The course provides a clear process, direct access to buyers, and the tools needed to complete a sale independently....

Read moreDetails

Crypto News: AlphaPepe DeFi Exchange Progress Hits 1,000 Demo Users whilst Dogecoin Price Prediction Points To $1.00

MONACO CITY, Monaco, April 25, 2026 (GLOBE NEWSWIRE) -- AlphaPepe has cleared a major product milestone as the AlphaSwap DeFi exchange demo moves beyond 1,000 active users ahead of the Q2 2026 exchange debut. The presale has also crossed $960,000 raised, passed 8,000 holders, and kept Stage 14 live at...

Read moreDetails

Study Shows Implicity’s New Agnostic Cloud-Based AI Algorithm Further Reduces False Alerts Even After Manufacturer AI Filtering in Modern Devices

CAMBRIDGE, Mass., April 25, 2026 (GLOBE NEWSWIRE) -- Implicity, a leader in remote patient monitoring and cardiac data management solutions, today announced the latest findings presented at the Heart Rhythm Society (HRS) 2026. The new HRS data extends on research presented earlier this month at the European Heart Rhythm Association...

Read moreDetails

95% Of AI Projects Fail to Deliver Business Impact, MIT-Affiliated Study Finds — German Startup Bucks the Trend, Appoints Georgios Pipelidis to Lead U.S. Expansion

Photo courtesy of Georgios Pipelidis Munich-based retail analytics company Ariadne has appointed CEO Georgios Pipelidis to lead its U.S. operations after his permanent relocation to the United States. MUNICH, April 25, 2026 (GLOBE NEWSWIRE) -- The move marks a corporate expansion update from the company, which says its deployment network...

Read moreDetails

HERE Technologies and MengQing expand intelligent navigation deployment for China’s leading commercial vehicle manufacturers

Joint solution integrates MengQing’s in‑vehicle navigation with HERE’s AI‑powered live map intelligence to support global expansion Enables consistent, compliant navigation for commercial fleets across international markets Delivers industry‑leading truck routing, ADAS and ISA capabilities Beijing, Auto China 2026 – HERE Technologies, the leading mapping and location data company, and MengQing, a...

Read moreDetails

HERE and KOTEI partner to build AI‑native navigation for the software‑defined vehicle era

Co-development reimagines navigation as a decision-driven, predictive experience that learns driver intent and adapts in real-time Platform approach enables automakers to curate AI-powered navigation and cockpit experiences across vehicles, regions and services Beijing, Auto China 2026 – HERE Technologies, the leading mapping and location data company, and KOTEI, a pioneer...

Read moreDetails

Apollo Group TV Introduces Unified Apollo TV App with Integrated Account and Subscription Management

NEW YORK, April 25, 2026 (GLOBE NEWSWIRE) -- Apollo Group TV today announced the release of an updated version of the Apollo TV app, bringing together account access, pricing, payment processing, and subscription management within a single, unified platform. The update is now available through the Apollo Group TV official...

Read moreDetails

HERE Technologies and Baidu Maps announce strategic MoU to bring advanced in‑vehicle navigation and intelligent driving map solutions to global automakers

HERE and Baidu Maps join hands to co-develop a seamless global navigation and intelligent driving map solution The partnership will deliver advanced navigation, integrated ADAS and ISA solutions and predictive signal timing capabilities for automakers Beijing, Auto China 2026 – HERE Technologies, the leading mapping and location data company, and Baidu...

Read moreDetails

Crypto News: AlphaPepe Presale Hits New Stage Milestones as Bitcoin Price Prediction Sets Target at $120,000

MONACO, April 24, 2026 (GLOBE NEWSWIRE) -- AlphaPepe has crossed another run of presale milestones as Stage 14 stays live at $0.01570 ahead of the Q2 2026 exchange debut. The presale has now moved beyond $950,000 raised, passed 8,000 holders, and pushed the AlphaSwap AI DEX demo beyond 1,000 active...

Read moreDetails
Web3Wire NFTs - The Web3 Collective

Web3Wire, $W3W Token and .w3w tld Whitepaper

Web3Wire, $W3W Token and .w3w tld Whitepaper

Claim your space in Web3 with .w3w Domain!

Web3Wire

Trending on Web3Wire

  • FlipHTML5’s Flipbook Maker Creates Interactive Digital Publications Easily

    8 shares
    Share 3 Tweet 2
  • Understanding Soulbound Tokens SBT Their Definition and Significance

    53 shares
    Share 21 Tweet 13
  • Discover 2025’s Top 5 Promising Low-Cap Crypto Gems

    98 shares
    Share 39 Tweet 25
  • Unifying Blockchain Ecosystems: 2024 Guide to Cross-Chain Interoperability

    159 shares
    Share 64 Tweet 40
  • The HUB @ Office Logic Introduces Structured Deal Flow Access, Investor Readiness Engine, and Accelerator Program at Startup OLÉ Miami 2026

    5 shares
    Share 2 Tweet 1
Join our Web3Wire Community!

Our newsletters are only twice a month, reaching around 10000+ Blockchain Companies, 800 Web3 VCs, 600 Blockchain Journalists and Media Houses.


* We wont pass your details on to anyone else and we hate spam as much as you do. By clicking the signup button you agree to our Terms of Use and Privacy Policy.

Web3Wire Podcasts

Upcoming Events

There are currently no events.

Latest on Web3Wire

  • Crypto News: AlphaPepe Presale Crosses $960,000 Raised as Bitcoin Price Prediction Aims at $200,000
  • How to Sell a Business Without a Broker: New Course Helps Owners Keep More of Their Money
  • Crypto News: AlphaPepe DeFi Exchange Progress Hits 1,000 Demo Users whilst Dogecoin Price Prediction Points To $1.00
  • Good Driver Club Publishes Eligible Events in Full Each Monday
  • The Story Behind Good Driver Club: Why Good Drivers Deserve to Keep More

RSS Latest on Block3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Covo Finance: Revolutionary Crypto Leverage Trading Platform
  • WorldStrides and HEX Announce Partnership to Offer High School and University Students Innovative Courses Designed to Improve Their Outlook in the Digital Age

RSS Latest on Meta3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Thumbtack Honored as a 2023 Transform Awards Winner
  • Accenture Invests in Looking Glass to Accelerate Shift from 2D to 3D
Web3Wire

Web3Wire is your go-to source for the latest insights and updates in Web3, Metaverse, Blockchain, AI, Cryptocurrencies, DeFi, NFTs, and Gaming. We provide comprehensive coverage through news, press releases, event updates, and research articles, keeping you informed about the rapidly evolving digital world.

  • About Web3Wire
  • Founder’s Note
  • Web3Wire NFTs – The Web3 Collective
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Event Partners
  • Community Partners
  • Our Media Network
  • Media Kit
  • RSS Feeds
  • Contact Us

Crypto Coins

  • Top 10 Coins
  • Top 50 Coins
  • Top 100 Coins
  • All Coins – Marketcap
  • Crypto Coins Heatmap

Crypto Exchanges

  • Top 10 Exchanges
  • Top 50 Exchanges
  • Top 100 Exchanges
  • All Crypto Exchanges

Crypto Stocks

  • Blockchain Stocks
  • NFT Stocks
  • Metaverse Stocks
  • Artificial Intelligence Stocks

Web3Wire Whitepaper | Tokenomics

Web3 Resources

  • Top Web3 and Crypto Youtube Channels
  • Latest Crypto News
  • Latest DeFi News
  • Latest Web3 News

Blockchain Resources

  • Blockchain and Web3 Resources
  • Decentralized Finance (DeFi) – Research Reports
  • All Crypto Whitepapers

Metaverse Resources

  • AR VR and Metaverse Resources
  • Metaverse Courses
Claim your space in Web3 with .w3w!

The Klyrox Protocol | The Algorithmic Monographs

Top 50 Web3 Blogs and Websites
Web3Wire Podcast on Spotify Web3Wire Podcast on Amazon Music 
Web3Wire - Web3 and Blockchain - News, Events and Press Releases | Product Hunt
Web3Wire on Google News

Media Portfolio: Block3Wire | Meta3Wire

  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Sitemap
  • For Search Engines
  • Crypto Sitemap
  • Exchanges Sitemap

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Coins
    • Top 10 Cryptocurrencies
    • Top 50 Cryptocurrencies
    • Top 100 Cryptocurrencies
    • All Coins
  • Exchanges
    • Top 10 Cryptocurrency Exchanges
    • Top 50 Cryptocurrency Exchanges
    • Top 100 Cryptocurrency Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.